Antiarrhythmic Drug Therapy
Mechanism of Action
- Class 1 antiarrhythmics do not interact with phase 4 of nodal action potentials because they primarily block fast sodium channels which are not the dominant ionic current during the spontaneous depolarization (phase 4) of nodal cells 1
- Class 1 antiarrhythmics block sodium channels with intermediate kinetics, have some potassium channel blocking effects, can prolong QT interval and action potential duration, and may cause torsades de pointes 2
- Class 1 antiarrhythmics block sodium channels with rapid kinetics, primarily affect ischemic or depolarized tissue, and have minimal effect on normal nodal tissue phase 4 3
- Class 1 antiarrhythmics are the most potent sodium channel blockers with slow kinetics, are contraindicated in structural heart disease, and have minimal direct effect on nodal phase 4 depolarization 4
Treatment of Arrhythmias
- For nodal arrhythmias, calcium channel blockers (class IV) or beta-blockers (class II) that directly affect phase 4 are typically more effective than class 1 drugs 5
- In patients with WPW syndrome and atrial fibrillation, class 1A drugs like procainamide are preferred over calcium channel blockers or digoxin, which would preferentially slow AV nodal conduction 5
Clinical Guidelines
- The American College of Cardiology recommends that class 1 drugs are generally not first-line agents for treating nodal arrhythmias, but are preferred for ventricular arrhythmias or arrhythmias involving accessory pathways 5